Valion Bio reported a gross margin of -115.38% for the quarter ended Jun 2026. These financial ratios cover 21 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||
| Gross Margin | -12.31% | -9.39% | -0.51% | 16.36% | 23.67% | 13.21% | 10.54% | 30.05% | 37.89% | 38.30% | 1.40% | 50.00% | 21.43% | 34.92% | -132.78% | 71.43% | 62.79% | -99.32% | 91.25% | -115.38% | |
| EBT Margin | -476.87% | -443.68% | -589.20% | -523.60% | -571.59% | -541.72% | -552.94% | -562.77% | -1,319.88% | -624.11% | -628.57% | -443.41% | -947.14% | -1,135.71% | -823.89% | -2,151.43% | -2,248.84% | -1,697.95% | |||
| EBIT Margin | -393.66% | -443.68% | -589.20% | -523.60% | -571.59% | -541.72% | -552.94% | -562.77% | -1,319.88% | -624.11% | -628.57% | -443.41% | -904.29% | -1,135.71% | -823.89% | -2,151.43% | -2,248.84% | -1,700.68% | |||
| EBITDA Margin | -393.66% | -443.68% | -589.20% | -523.60% | -571.59% | -541.72% | -552.94% | -562.77% | -1,319.88% | -624.11% | -628.57% | -443.41% | -904.29% | -1,135.71% | -823.89% | -2,151.43% | -2,248.84% | -1,700.68% | |||
| Operating Margin | -393.66% | -443.68% | -589.20% | -523.60% | -571.59% | -541.72% | -552.94% | -562.77% | -1,319.88% | -624.11% | -628.57% | -443.41% | -904.29% | -1,135.71% | -823.89% | -2,151.43% | -2,248.84% | -1,700.68% | |||
| Net Margin | -476.87% | -443.68% | -589.20% | -523.36% | -571.59% | -541.72% | -552.94% | -562.77% | -1,319.88% | -624.11% | -628.57% | -443.41% | -947.14% | -1,135.71% | -823.89% | -2,151.43% | -2,248.84% | -1,697.95% | |||
| FCF Margin | -202.61% | -593.50% | -709.51% | -515.42% | -325.76% | -583.86% | -543.87% | -670.21% | -1,551.55% | -651.42% | -496.92% | -508.98% | -928.57% | -1,111.11% | -736.11% | -1,285.71% | -2,111.63% | -1,373.97% | -2,891.25% | ||
| Efficiency | |||||||||||||||||||||
| Inventory AverageInventory Avg. | 0.44M | 0.64M | 0.80M | 0.81M | 0.90M | 0.97M | 0.96M | 0.86M | 0.80M | 0.80M | 0.77M | 0.69M | 0.65M | 0.63M | 0.60M | 0.38M | 0.47M | ||||
| Assets AverageAssets Avg. | 13.87M | 11.86M | 9.62M | 7.04M | 6.49M | 5.85M | 5.80M | 6.08M | 4.22M | 4.03M | 4.09M | 3.10M | 3.29M | 4.14M | 5.37M | 18.92M | 32.04M | ||||
| Invested CapitalInvested Cap. | 4.08M | ||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.10 | 0.14 | 0.19 | 0.26 | 0.28 | 0.24 | 0.21 | 0.19 | 0.27 | 0.28 | 0.23 | 0.25 | 0.16 | 0.11 | 0.09 | 0.02 | 0.01 | ||||
| Leverage & Solvency | |||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -4.73 | -21.10 | |||||||||||||||||||
| Debt Ratio | 0.08 | ||||||||||||||||||||
| Times Interest Earned | -4.73 | -21.10 | |||||||||||||||||||
| Valuation | |||||||||||||||||||||
| Price to EarningsP/E | -402.12 | -474.80 | -422.73 | -3.69 | -1.87 | -0.97 | -1.01 | -0.80 | -0.43 | -0.85 | -0.80 | -0.74 | -0.05 | -0.05 | -0.08 | -0.06 | |||||
| Price to SalesP/S | 0.00M | 0.00M | 0.00M | 20.00 | 10.32 | 5.48 | 13.27 | 4.96 | 2.72 | 3.75 | 7.60 | 8.41 | 0.38 | 1.03 | 1.86 | 1.05 | 0.84 | 1.80 | |||
| Price to BookP/B | 69.44 | 95.88 | 155.83 | 1.65 | 1.16 | 0.40 | 0.68 | 0.24 | 0.27 | 0.58 | 0.25 | 0.37 | 0.03 | 0.02 | 0.04 | 0.04 | 0.00 | 0.02 | |||
| Enterprise Value | 908.69M | 1,052.76M | 1,266.76M | 3.21M | 0.69M | -3.14M | -0.56M | -3.80M | -2.42M | -0.45M | -2.64M | -1.14M | -1.93M | -0.63M | -1.02M | -3.35M | -12.58M | -2.13M | |||
| EV to EBIT | -396.46 | -469.77 | -419.73 | -1.24 | -0.31 | 1.48 | 0.26 | 2.16 | 1.08 | 0.30 | 2.08 | 0.80 | 1.30 | 0.42 | 0.53 | 1.35 | |||||
| EV to EBITDA | -396.46 | -469.77 | -419.73 | -1.24 | -0.31 | 1.48 | 0.26 | 2.16 | 1.08 | 0.30 | 2.08 | 0.80 | 1.30 | 0.42 | 0.53 | 1.35 | |||||
| Market Capitalization | 921.67M | 1,063.56M | 1,275.81M | 9.54M | 4.21M | 2.06M | 2.14M | 1.40M | 0.97M | 1.25M | 1.06M | 1.06M | 0.07M | 0.07M | 0.16M | 0.15M | 0.07M | 0.07M | |||
| Price to FCFP/FCF | -333.94 | -482.12 | -741.75 | -3.43 | -1.90 | -0.82 | -0.86 | -0.76 | -0.55 | -0.74 | -0.82 | -0.76 | -0.05 | -0.08 | -0.09 | -0.08 | -0.03 | ||||
| EV to FCF | -329.24 | -477.22 | -736.49 | -1.15 | -0.31 | 1.25 | 0.23 | 2.07 | 1.37 | 0.26 | 2.03 | 0.81 | 1.46 | 0.70 | 0.56 | 1.67 | 5.44 | ||||
| EV to CFO | -329.24 | -478.53 | -736.49 | -1.16 | -0.31 | 1.29 | 0.23 | 2.07 | 1.37 | 0.26 | 2.03 | 0.81 | 1.46 | 0.70 | 0.56 | 1.68 | 5.50 | ||||
| Return Ratios | |||||||||||||||||||||
| Return on Sales [ROS]ROS | -393.66% | -443.68% | -589.20% | -523.60% | -571.59% | -541.72% | -552.94% | -562.77% | -1,319.88% | -624.11% | -628.57% | -443.41% | -904.29% | -1,135.71% | -823.89% | -2,151.43% | -2,248.84% | -1,700.68% | |||
| Return on Capital Employed [ROCE]ROCE | -53.39% | -92.60% | -133.46% | -195.58% | -202.93% | -193.69% | -171.97% | -176.14% | -235.64% | -196.05% | -182.00% | -200.14% | -222.89% | -191.30% | -156.56% | ||||||
| Return on Assets [ROA]ROA | -50.78% | -74.03% | -105.39% | -143.42% | -153.73% | -155.27% | -142.33% | -135.56% | -180.27% | -168.82% | -158.54% | -184.52% | -174.54% | -153.39% | -137.88% |